Navy General Hospital, Beijing
Clinical trials sponsored by Navy General Hospital, Beijing, explained in plain language.
-
Smartwatch trial aims to predict and prevent AF complications
Disease control Not yet recruitingThis study will test if using a smartwatch to continuously monitor atrial fibrillation (AF) can help doctors decide when to start or change treatment. About 3,194 people with paroxysmal AF will wear a smartwatch that tracks their AF burden. Those with a high burden will receive e…
Phase: NA • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for tough lymphoma: drug cocktail aims to beat relapsed disease
Disease control Not yet recruitingThis study tests a combination of three drugs (glofitamab, polatuzumab vedotin, and GemOx) as an initial intensive treatment for people with aggressive B-cell lymphoma that has not responded to therapy or has returned. About 80 adults will take part to see if the combo is safe an…
Phase: PHASE2 • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
10,000 smartwatch users to track AF burden and stroke risk in landmark study
Knowledge-focused Not yet recruitingThis study will follow 10,000 people with atrial fibrillation (AF) for two years to see if the total time they spend in AF (called AF burden) is linked to strokes and blood clots. Participants will use their own smartphones and smartwatches to track their heart rhythm. The goal i…
Sponsor: Navy General Hospital, Beijing • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC